INDICATIONS AND USAGE
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Synercid and other antibacterial drugs, Synercid should be used...
Did you find an answer to your question?
Yes
No
SYNERCID®(quinupristin, dalfopristin)
SYNERCID® Quick Finder
Contraindications
CONTRAINDICATIONS
Synercid is contraindicated in patients with known hypersensitivity to Synercid, or with prior hypersensitivity to other streptogramins (...
Did you find an answer to your question?
Yes
No
Warnings and Precautions
WARNINGS
Drug Interactions
In vitro drug interaction studies have demonstrated that Synercid significantly...
Did you find an answer to your question?
Yes
No
Adverse Reactions
ADVERSE REACTIONS
The safety of Synercid was evaluated in 1099 patients enrolled in 5 comparative clinical trials. Additionally, 4 non-comparative clinical trials (3 prospective and 1 retrospective...
Did you find an answer to your question?
Yes
No
Overdosage
OVERDOSAGE
There are four reports of patients receiving Synercid doses at up to three times that recommended (7.5 mg/kg). No adverse events were considered possibly or probably related to...
Did you find an answer to your question?
Yes
No
Description
DESCRIPTION
Synercid® (quinupristin and dalfopristin powder for injection) I.V., a streptogramin antibacterial agent for intravenous administration, is a sterile lyophilized...
Did you find an answer to your question?
Yes
No
Clinical Pharmacology
CLINICAL PHARMACOLOGY
Pharmacokinetics
Quinupristin and dalfopristin are the main active components circulating in plasma in human subjects. Quinupristin and...
Did you find an answer to your question?
Yes
No
Clinical Studies
CLINICAL STUDIES
COMPARATIVE TRIALS
Complicated Skin and Skin Structure Infections
Two randomized, open-label...
Did you find an answer to your question?
Yes
No
How Supplied/Storage and Handling
HOW SUPPLIED
Synercid is supplied as a sterile lyophilized pyrogen-free preparation in single-dose 10 mL type I glass vials with gray elastomeric closure, and aluminum seal with a dark blue flip-off...
Did you find an answer to your question?
Yes
No
Did you find an answer to your question?
Yes
No
Report Adverse Event
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at(800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.
(800)-332-1088.